Interestingly, a later study demonstrated that PRDM1/BLIMP1 played an essential role in transforming growth factor (TGF)-β1-induced epithelial–mesenchymal transition (EMT) signature and cell migration of breast cancer cells via BMP-5 repression (Figure 1B) [38]. Here, PRDM1 is linked to breast carcinoma.